Example: Heart Attack

Search clinical trials for: Modulation of FiO2

Total 10000 results

NCT06020560

Recruiting

Study of Low Molecular Weight Heparins (DANHEP)

Venous Thromboembolism | Treatment | Prophylaxis | Anticoagulant
NCT05468242

Recruiting

Study of Tislelizumab for Locally Advanced Non-Small Cell Lung Cancer Following Neoadjuvant Chemotherapy Plus Tislelizumab ± Bevacizumab and Definitive Concurrent Chemoradiation Therapy

Stage III Non-small Cell Lung Cancer
NCT05117125

Recruiting

Biomarkers for Ventilator-associated Pneumonia (VAPmarkers)

Pneumonia, Ventilator-Associated
NCT04627363

Not yet recruiting

HAIC Combined With Bevacizumab and Toripalimab for Advanced Hepatocellular Carcinama

Liver Neoplasms | Hepatocellular Carcinoma | Bevacizumab | Toripalimab | Oxaliplatin
NCT04472806

Recruiting

Maintenance Treatment of Toripalimab(JS001) in Patients With Unresectable Locally Advanced or Metastatic Mucosal Melanoma (MTAM)

Mucosal Melanoma
NCT06903299

Active, not recruiting

Prospective Investigation of Intra-Articular Tranexamic Acid Use in Elective Hip Arthroplasty

Blood Loss | Blood Transfusion | Heterotopic Ossification | Hemoglobin Change
NCT04547634

Completed

Telerehabilitation in Oncology Patients

Cancer | Survivorship | Cancer Metastatic
NCT03957707

Active, not recruiting

Sterotactic Operation Integrating With Thrombolysis in Basal Ganglion Hemorrhage Evacuation (SOITBE)

Basal Ganglia Haematoma
NCT05511038

Completed

A Study to Learn How Safe the Study Drug Intravitreal (Given by an Injection Into the Eye) Aflibercept is in Participants in India With Diabetic Macular Edema (VISION-AF)

Diabetic Macular Edema
NCT03362190

Completed

ZIMURA in Combination With LUCENTIS in Patients With Neovascular Age Related Macular Degeneration (NVAMD)

Neovascular Age-related Macular Degeneration
NCT03701711

Terminated

Lenalidomide in Anti-MAG Neuropathy: Phase 1b Study

Demyelinating Sensorimotor Neuropathy
NCT04735861

Completed

Sintilimab Plus Bevacizumab in Recurrent/Persistent Ovarian Clear Cell Carcinoma (INOVA)

Ovarian Clear Cell Carcinoma
NCT04634604

Terminated

A Randomized Trial of Low-Dose Bevacizumab vs Laser for Type 1 ROP (ROP3)

Retinopathy of Prematurity
NCT00648024

Completed

Fasting Study of Anagrelide Hydrochloride Capsules 1 mg to Agrylin® Capsules 1 mg

Healthy
NCT05919615

Completed

Use of Tranexamic Acid in the Total Knee Arthroplasty.

Knee Osteoarthritis | Blood Loss | Blood Transfusion
NCT04443920

Completed

Tranexamic Acid for Total Knee Arthroscopy

Blood Loss, Surgical
NCT05434533

Completed

The Prophylactic Role of Tranexamic Acid in High Risk Pregnant Women Undergoing Elective Cesarean Section in Prevention of Postpartum Hemorrhage

High Risk Pregnant Women Undergoing Elective Cesarean Section
NCT05587062

Completed

Efficacy and Safety of Aflibercept in Patients With Neovascular Age-related Macular Degeneration

Age-Related Macular Degeneration | Neovascular Age-related Macular Degeneration
NCT02336165

Completed

Phase 2 Study of Durvalumab (MEDI4736) in Patients With Glioblastoma

Glioblastoma
NCT02412982

Completed

Evaluation of Venous Thromboembolism Prevention in High-Risk Trauma Patients

Venous Thromboembolism | Traumatic Injury
NCT04592029

Active, not recruiting

TACE Combined With Sintilimab and Bevacizumab for Unresectable HCC

Hepatocellular Carcinoma Non-resectable
NCT02076152

Completed

FMISO PET Study of Glioblastoma

Recurrent Glioblastoma
NCT01969708

Completed

Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) (SCORE2)

Central Retinal Vein Occlusion
NCT03394573

Terminated

Comparison of VA Guided Versus OCT Guided TER Using Aflibercept for Diabetic Macular Edema (AVOCT Study) (AVOCT)

Diabetic Macular Edema
NCT03000673

Completed

A Study to Evaluate Safety of Single Doses of BMS-986177 in Patients With End Stage Renal Disease (ESRD) Treated With Hemodialysis

Antithrombotic
NCT03083990

Completed

Compare IBI305 and Bevacizumab on Pharmacokinetics/Safety/Immunogenicity on Healthy Male

Healthy
NCT04003792

Unknown

Treatment With Hepatic Arterial Infusion of Oxaliplatin in Combination With Systemic FOLFIRI Chemotherapy and Bevacuzimab in Patients With Liver-only Colorectal Liver Metastases (CRLM): Conversion to Complete Resection in Patients With Initially Inoperable Liver-only CRLM.

Liver Metastasis Colon Cancer
NCT03348826

Withdrawn

Study of Sodium Bicarbonate in Restoring Blocked Catheters

Cancer | Central Venous Catheterization
NCT04508439

Unknown

Effect of the Use of Anticoagulant Therapy During Hospitalization and Discharge in Patients With COVID-19 Infection

Pneumonia | Covid19 | Coagulation Disorder | Pulmonary Embolism
NCT04186702

Completed

New Concepts in Diabetic Macular Edema (DME) (DME)

Diabetes Mellitus, With Complications
NCT03715296

Unknown

Lenalidomide Based Immunotherapy in the Treatment of DLBCL

Diffuse Large B Cell Lymphoma
NCT03920566

Unknown

The Effect of ENZAlutamide on the Anti-Xa Levels of Patients Receiving DOACs (ENZA-D)

Drug Interaction
NCT00837330

Completed

Ranibizumab (Lucentis) for Polypoidal Choroidal Vasculopathy

Polypoidal Choroidal Vasculopathy
NCT02385461

Unknown

Study on Antithrombotic Prevention in Thrombophilia and Pregnancy Loss (OTTILIA)

Pregnancy Complications
NCT01069627

Completed

A Study of Avastin (Bevacizumab) in Combination With Fotemustine in Patients With Metastatic Melanoma

Malignant Melanoma
NCT02030821

Completed

TXA vs. Amicar in Total Knee and Hip Arthroplasty

Blood Loss | Knee Arthritis | Hip Arthritis
NCT01190345

Completed

Anti Cancer Stem Cell Activity of Pre-operative Bevacizumab and Chemotherapy in Breast Cancer (AVASTEM)

Breast Cancer
NCT01591096

Terminated

Thrombolysis in Pediatric Stroke (TIPS) (TIPS)

Stroke
NCT02164565

Withdrawn

The Use of Tranexamic Acid (TXA) Intravenously, to Reduce Blood Loss in Proximal Femur Surgery

Femur Surgery
NCT01338558

Withdrawn

A Study of Avastin (Bevacizumab) in Combination With mFOLFOX6 in Treatment-Naïve Patients With Metastatic Colorectal Cancer With or Without K-RAS Mutations, and Comparison to Cetuximab

Colorectal Cancer
NCT00336323

Completed

A Phase 2 Evaluation of Anti-VEGF Therapy for Diabetic Macular Edema: Bevacizumab (Avastin) (Bevacizumab)

Diabetic Retinopathy
NCT00596362

Completed

Treatment With Intravitreal Avastin for Large Uveal Melanomas

Uveal Melanoma
NCT01474239

Completed

A Study of Avastin (Bevacizumab) And Fotemustine in Patients With Recurrent Glioblastoma

Glioblastoma Multiforme
NCT00727753

Completed

VEGF-antagonism and Endothelial Function in Age-related Macular Degeneration (AMD)

Macular Degeneration
NCT01501162

Completed

Effect of Probiotics on Gut-Liver Axis of Alcoholic Liver Disease (EPALD)

Alcoholic Liver Disease
NCT01554059

Completed

Neoadjuvant Chemoradiation With Bevacizumab for Chinese Rectal Cancer Patients (New Beat)

Rectal Adenocarcinoma
NCT00359424

Terminated

Interventional Management of Stroke (IMS) III Trial (IMSIII)

Stroke
NCT00894829

Completed

Efficacy and Safety of Sodium Heparin (Eurofarma)

Cardiac Surgery
NCT01020747

Completed

Bevacizumab for Treatment of Recurrent Respiratory Papillomatosis (RRP)

Recurrent Respiratory Papillomatosis
NCT01123564

Unknown

Efficacy and Safety of Lucentis for Clinically Significant Macular Edema Secondary to Central Retinal Vein Occlusion (BRAVO)

Macular Edema | Retinal Vein Occlusion

Search clinical trials for: Modulation of FiO2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations